ResearchMoz

Liver Cancer Global Clinical Trials Review, H2, 2012

GlobalData
Published Date » 2012-12-12
No. Of Pages » 159
     
  Liver Cancer Global Clinical Trials Review, H2, 2012  
     
  Summary  
   
 GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Cancer. This report is built using data and information sourced from proprietary databases, primary...
Table of Contents

Table of Contents 2

List of Tables 5
List of Figures 6
Introduction 7
Liver Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Five Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Liver Cancer 24
Subjects Recruited Over a Period of Time 36
Prominent Sponsors 37
Top Companies Participating in Liver Cancer Therapeutics Clinical Trials 39
Prominent Drug Comparison 41
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
Bayer AG 42
Clinical Trial Overview of Bayer AG 42
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Taiho Pharmaceutical Co., Ltd. 46
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Celsion Corporation 49
Clinical Trial Overview of Celsion Corporation 49
Pathfinder Therapeutics, Inc. 50
Clinical Trial Overview of Pathfinder Therapeutics, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Jennerex Biotherapeutics, Inc. 52
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 52
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Eli Lilly and Company 54
Clinical Trial Overview of Eli Lilly and Company 54
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Merck & Co., Inc. 56
Clinical Trial Overview of Merck & Co., Inc. 56
Light Sciences Oncology, Inc. 57
Clinical Trial Overview of Light Sciences Oncology, Inc. 57
Kowa Company, Ltd. 58
Clinical Trial Overview of Kowa Company, Ltd. 58
ArQule, Inc. 59
Clinical Trial Overview of ArQule, Inc. 59
BioAlliance Pharma SA 60
Clinical Trial Overview of BioAlliance Pharma SA 60
Eisai Inc. 61
Clinical Trial Overview of Eisai Inc. 61
Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Top Universities / Institutes / Hospitals 63
Eastern Hepatobiliary Surgery Hospital 63
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 63
The University of Texas M. D. Anderson Cancer Center 66
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 66
Sun Yat-sen University 69
Clinical Trial Overview of Sun Yat-sen University 69
FUDAN University 71
Clinical Trial Overview of FUDAN University 71
Memorial Sloan Kettering Cancer Center 73
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 73
National Taiwan University Hospital 75
Clinical Trial Overview of National Taiwan University Hospital 75
Massachusetts General Hospital 76
Clinical Trial Overview of Massachusetts General Hospital 76
National Cancer Center Hospital 78
Clinical Trial Overview of National Cancer Center Hospital 78
University of Pittsburgh 79
Clinical Trial Overview of University of Pittsburgh 79
Stanford University 80
Clinical Trial Overview of Stanford University 80
Seoul National University Hospital 81
Clinical Trial Overview of Seoul National University Hospital 81
West China Hospital 82
Clinical Trial Overview of West China Hospital 82
University Health Network 83
Clinical Trial Overview of University Health Network 83
Kaohsiung Medical University Chung-Ho Memorial Hospital 84
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 84
University of Milan 85
Clinical Trial Overview of University of Milan 85
Roswell Park Cancer Institute 86
Clinical Trial Overview of Roswell Park Cancer Institute 86
Mayo Clinic 87
Clinical Trial Overview of Mayo Clinic 87
Kurume University 88
Clinical Trial Overview of Kurume University 88
Queen Mary Hospital 89
Clinical Trial Overview of Queen Mary Hospital 89
Kyoto University 90
Clinical Trial Overview of Kyoto University 90
Five Key Clinical Profiles 91

Appendix 156
Abbreviations 156
Definitions 156
Research Methodology 157
Secondary Research 157
About GlobalData 158
Contact Us 158
Disclaimer 158
Source 159

List of Tables


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries, 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 38
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 40
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 42
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 44
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 46
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 47
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 48
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 49
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pathfinder Therapeutics, Inc., 2012* 50
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 51
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012* 52
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 53
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 54
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 55
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 56
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 57
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2012* 58
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 59
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioAlliance Pharma SA, 2012* 60
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Cancer Treatment International Limited, 2012* 62
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2012* 63
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 66
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 69
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 71
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 73
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 75
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 76
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2012* 78
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 79
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 80
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 81
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2012* 82
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 83
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2012* 84
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 85
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 86
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 87
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University, 2012* 88
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2012* 89
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 90

List of Figures


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries (%), 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 39
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
GlobalData Methodology 157

Upcoming Reports:

Global Market for Marine Derived Drugs Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Over 50% of the world’s most popular drugs are sourced directly or indirectly from natural sources. Pioneering research in marine based drug discovery began with Roche Research Institute of Marine Pharmacology during the mid 1970s. Tethya crypta a marine sponge was the first organism to be commercialized to produce drugs against HIV & Herpes. A small number of marine organisms primarily constituting of algae and other invertebrates have already been researched for commercial value in pharmaceuticals.  Marine organisms have been found to be capable of providing...
NFC Technology Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Near field communication (NFC) has been around since past few years but was not yet implemented as it was undergoing pilot testing phase. Considerable research and developments have been made in this field and several prototypes are developed for number of products and applications. Major application areas of NFC include mobile payments, data sharing, and advertisement among others. Although there are limited products commercially available today using NFC technology, this market is expected to witness immense growth in product and applications in upcoming few years.  NFC...
Antimony Trioxide Market - Global Industry Analysis, Size, Share, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Antimony trioxide is the one of the major compounds of antimony. Antimony oxide is mainly produced by two ways either by oxidation of antimony or by the process of re-volatilizing of crude antimony trioxide. The method of production is mainly dependent on the composition of ores. Antimony trioxide has the ability to react both as acid as well as base making it suitable in various end user applications. Antimony trioxide reacts with mineral acids to give the corresponding salts. The major applications of antimony trioxide include flame retardants, polymerization catalyst in manufacturing...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...